+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Trinity Biotech Plc (TRIB) - Financial and Strategic SWOT Analysis Review

Trinity Biotech Plc (TRIB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Trinity Biotech Plc (Trinity Biotech) is biotechnology company that focuses on the development, acquisition, manufacturing, and marketing of diagnostic systems. The company’s product portfolio encompasses diagnostic tests and instruments that are used to detect hemoglobin A1c for diabetes monitoring and diagnosis, infectious diseases, autoimmune, sexually transmitted diseases, and liver and intestine disorders. Trinity Biotech markets its products through direct sales in the US, Brazil, Germany, France and the UK; and through a network of distributors and strategic partnerships in other countries. The company has manufacturing facilities in the US, Brazil, and Ireland. Trinity Biotech is headquartered in Bray, County Wicklow, Ireland.

Trinity Biotech Plc Key Recent Developments

  • Aug 20, 2024: Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
  • Jul 09, 2024: Trinity Biotech Announces Appointment of A New CFO
  • Jun 24, 2024: Trinity Biotech to Begin European Pre-pivotal Trial to Optimize Its CGM Sensor
  • May 16, 2024: Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Trinity Biotech Plc - Key Facts
  • Trinity Biotech Plc - Key Employees
  • Trinity Biotech Plc - Key Employee Biographies
  • Trinity Biotech Plc - Major Products and Services
  • Trinity Biotech Plc - History
  • Trinity Biotech Plc - Company Statement
  • Trinity Biotech Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Trinity Biotech Plc - Business Description
  • Product Category: Clinical Laboratory Goods
  • Performance
  • Product Category: Clinical Laboratory Services
  • Performance
  • Product Category: Point-of-Care
  • Performance
  • Geographical Segment: Americas
  • Performance
  • Geographical Segment: Asia/Africa
  • Performance
  • Geographical Segment: Europe (including Ireland)
  • Performance
  • R&D Overview
  • Trinity Biotech Plc - Corporate Strategy
  • Trinity Biotech Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Trinity Biotech Plc - Strengths
  • Trinity Biotech Plc - Weaknesses
  • Trinity Biotech Plc - Opportunities
  • Trinity Biotech Plc - Threats
  • Trinity Biotech Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Trinity Biotech Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Trinity Biotech Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Trinity Biotech Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Aug 20, 2024: Trinity Biotech Appoints Diabetes Care Veteran as Biosensor Marketing Director
  • Jul 09, 2024: Trinity Biotech Announces Appointment of A New CFO
  • Jun 24, 2024: Trinity Biotech to Begin European Pre-pivotal Trial to Optimize Its CGM Sensor
  • May 16, 2024: Trinity Biotech Announces Strategic Collaboration with Medical Artificial Intelligence Company PulseAI
  • May 08, 2024: Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development
  • Apr 04, 2024: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
  • Dec 18, 2023: Trinity Biotech Announces Management Changes
  • Jul 06, 2023: Trinity Biotech Announces Q1 2023 Financial Results
  • Mar 23, 2023: Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results
  • Jan 09, 2023: Trinity Biotech Announces Strategic Partnership with imaware to Deliver Integrated Diagnostic Testing Solutions to Digital Health Industry
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Trinity Biotech Plc, Key Facts
  • Trinity Biotech Plc, Key Employees
  • Trinity Biotech Plc, Key Employee Biographies
  • Trinity Biotech Plc, Major Products and Services
  • Trinity Biotech Plc, History
  • Trinity Biotech Plc, Subsidiaries
  • Trinity Biotech Plc, Key Competitors
  • Trinity Biotech Plc, Ratios based on current share price
  • Trinity Biotech Plc, Annual Ratios
  • Trinity Biotech Plc, Interim Ratios
  • Trinity Biotech Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Trinity Biotech Plc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • Trinity Biotech Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Trinity Biotech Plc, Performance Chart (2019 - 2023)
  • Trinity Biotech Plc, Ratio Charts
  • Trinity Biotech Plc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • Trinity Biotech Plc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DiaSorin Inc
  • Siemens Healthineers AG
  • Becton Dickinson and Co
  • DexCom Inc
  • Abbott Diagnostics
  • Thermo Fisher Scientific Inc
  • Sebia
  • Tosoh Corp
  • Johnson & Johnson
  • Bio-Rad Laboratories Inc
  • Arkray Inc
  • WerfenLife SA
  • Roche Diagnostics